Arlington Trust’s Select Medical SEM Stock Holding History

Arlington Trust’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16	Closed	-$243	–	684
2025 Q2	$243	Buy	+16	New	+$250	﹤0.01%	681

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arlington Trust's SEM Position: Q3 2025 in Review

Arlington Trust sold out of Select Medical (SEM) in Q3 2025, closing a stake of 16 shares — an estimated $243 sold.

Arlington Trust first reported a position in SEM in Q2 2025 and held it in 1 quarter. The position peaked at $243 in Q2 2025. 268 funds tracked by Wall St. Rank hold SEM as of Q3 2025.

Arlington Trust reported no remaining Select Medical position as of Q3 2025 after selling out during the quarter.
Arlington Trust sold 16 Select Medical shares in Q3 2025, an estimated $243.
Arlington Trust first reported a position in Select Medical in Q2 2025 and held it in 1 quarter.
Arlington Trust's Select Medical position peaked at $243 in Q2 2025.
268 funds tracked by Wall St. Rank held Select Medical as of Q3 2025.

Based on Arlington Trust's 13F filing for Q3 2025, filed 28 Oct 2025.